Results 161 to 170 of about 1,271,889 (407)

Interleukin -2 ( Il-2 ) and Gamma Interferon ( Ifn ? ) of Lymphocyte Culture Supernatant in Iron Deficiency Anemia Patients with Infection [PDF]

, 2010
Iron is an essential nutrient for every living cells because of it role as molecule fortransport of oxygen, as well as DNA synthesis through synthesis of ribonucleotidereductase.
Bakta, I. M. (I), D, A. S. (AAG), Suata, K. (Ketut), Suega, K. (Ketut)   +3 more
core  

SPLENIC ANEMIA IN A FIVE-YEAR-OLD BOY [PDF]

, 1909
Van Buren Knott
openalex   +1 more source

PB2546: DIAGNOSTIC POWER OF ERYTHROCYTE AND RETICULOCYTE AUTOMATIC PARAMETERS IN THE SCREENING FOR CONGENITAL HEMOLYTIC ANEMIAS

HemaSphere, 2023
Paola Bianchi, Azita Sharif, Cristina Vercellati, Elisa Fermo, Maria Laura Chiaretto, Anna Paola Marcello, Anna Zaninoni, Nadi Mirra, Simona Torricelli, Virna De Zordi, Stefania Bottalico, Wilma Barcellini, Ferruccio Ceriotti, Anna Chiara Migliorini   +13 more
doaj   +1 more source

Anemia and Associated Factors among Public Elementary School Children in Asella Town, Southeast Ethiopia: A Facility-Based Cross-Sectional Study

Anemia
Background. Anemia has a negative impact on school children, including poor physical growth and reduced mental performance. Children show poor attentiveness, behavior, and memory and reduced school performance.
Ararso Hordofa Guye, Kasim Hansa, Kasahun Ketema, Meseret Moroda, Dame Banti Shambi   +4 more
doaj   +1 more source

Comorbidities in Mild WAS/XLT Require Lifelong Follow‐Up and Consideration of Definitive Treatment

American Journal of Hematology, EarlyView.
Our study followed the clinical and biological course of 261 WAS/XLT patients, including 170 with a mild form of the disease. The occurrence of late complications even in mild patients confirms the importance of offering lifelong follow‐up and considering definitive treatment (HSCT/gene therapy) for all patients.
Coralie Mallebranche, Charline Miot, Mickael Alligon, Despina Moshous, Benedicte Neven, Vincent Barlogis, Virginie Courteille, Bénédicte Bruno, Marie Ouachée‐Chardin, Dalila Adjaoud, Yves Delneste, Olivier Bouaziz, Capucine Picard, Alain Fischer, Nizar Mahlaoui, Isabelle Pellier, Members of the CEREDIH French PID Study Group   +16 more
wiley   +1 more source

The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. [PDF]

, 2020
Sickle cell disease (SCD) is an extremely heterogeneous disease that has been associated with global morbidity and early mortality. More effective and inexpensive therapies are needed.
Ballas, Samir K
core   +1 more source

A CASE OF PERNICIOUS ANEMIA [PDF]

, 1910
B. P. ROSENBERRY
openalex   +1 more source

Triple A Plus (AAA+) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients

American Journal of Hematology, EarlyView.
A new risk model for essential thrombocythemia that is based on complete blood cell count‐derived parameters and host‐related factors. ABSTRACT Survival prediction models in essential thrombocythemia (ET) include the International Prognostic Scoring System (IPSET) and the more recently introduced triple‐A (AAA) prognostic score.
Ayalew Tefferi, Giuseppe G. Loscocco, Lior Rokach, Tamar Tadmor, Priyansh Faldu, Guy Melamed, Hilel Alapi, Maymona Abdelmagid, Rania M. Abdelaziz, Muhammad Yousuf, Merry Nakhleh, Animesh Pardanani, Kebede H. Begna, Mirnal M. Patnaik, Natasha Szuber, Alessandra Carobbio, Tiziano Barbui, Kaaren K. Reichard, Rong He, Paola Guglielmelli, Naseema Gangat, Alessandro M. Vannucchi   +21 more
wiley   +1 more source

INFANTILE PSEUDOLEUKEMIC ANEMIA. [PDF]

, 1906
JosephW. Hunt
openalex   +1 more source

Not All Hereditary Iron Overload Is Hemochromatosis: A Case of Hereditary Xerocytosis Unmasked by Blood Smear Morphology

American Journal of Hematology, EarlyView.
María‐Angustias Molina‐Arrebola, Barbara J. Bain   +1 more
wiley   +1 more source